·    İç Hastalıkları A.D.:

•     Nefroloji Bilim Dalı,
•      Gastroenteroloji Bilim Dalı,
•      Hematoloji Bilim Dalı,
•     Tıbbi Onkoloji Bilim Dalı,
•      Romatoloji Bilim Dalı,
•      Endokrinoloji ve Metabolizma Hastalıkları Bilim Dalı
•      3. Basamak Yoğun Bakım bilim dallarından oluşmaktadır.

birimleri ile eğitim, hasta hizmeti ve araştırma faaliyetlerini sürdürmektedir. Bilim Dalları uzmanlık alanları ile ilgili her türlü olanağa sahip bulunmaktadır. Böbrek ve karaciğer nakli işlemleri ünitelerimizde yapılmaktadır. 

Son İki Yılda Uluslararası Dergilerde Yayınlanan Makaleler

2024
34. Tezcan, D.; Eryavuz onmaz, D.; Körez, M.; Limon, M.; Gülcemal, S.; Yılmaz, S.; Sivrikaya, A. The role of fatty acids in patients with Behçets disease and their association with thrombosis. LIPIDS, 2024, , 1-11.
10.1002/lipd.12398

33. Limon, M. Kartagener's syndrome and undifferentiated connective tissue disease. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASE, 2024, 27, 1-3.
10.1111/1756-185X.15179

32. özdoğan, O.; Altıntaş, E.; Kasap, E.; Sezgin, O.; Oğuz, D.; Yaraş, S. Turkish Society of Gastroenterology: Pancreas Working Group, Acute Pancreatitis Committee Consensus Report. TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35, 1-44.
10.5152/tjg.2024.24392

31. Yildirim, N.; Balcı, �.; Tamer, L. Reduced Expression of miRNAs as Potential Biomarkers in Axial Spondyloarthritis. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70, 1-6.
10.1590/1806-9282.20231521

30. Güngör semiz, G.; Demir, T.; Yıldırım şimşir, I.; Selimoğlu, �.; Yılmaz, M.; Elidokuz, H.; Onay, H.; Gen, R.; Evren, B. Evaluation of Coronavirus Disease 2019-Related Morbidity and Mortality in Lipodystrophy Patients During the Pandemic Period. ENDOCRINOLOGY RESEARCH AND PRACTICE, 2024, 28, 151-155.
10.5152/erp.2024.23352

29. Köşeci, T.; Seyyar, M.; Aydınalp, Y.; çelik, H.; Mete, B.; Demirhindi, H.; Ata, S.; Solmaz, A.; çil, T. HALP Score in Predicting Response to Treatment in Patients with Early-Stage Gastric Cancer: A Multi-Centred Retrospective Cohort Study. MEDICINA, 2024, 60, 2087-2098.
10.3390/medicina60122087

28. özdoğan, O.; Altıntaş, E.; Kasap, E.; Sezgin, O.; Oğuz, D.; Soytürk, M.; Bengi, G. Prevalence of Pancreatic Steatosis and Its Associated Factors in Turkey: A Nation-Wide Multicenter Study. TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35, 239-254.
10.5152/tjg.2024.23583

27. Koçar, �.; özcan, P.; Koç, Z.; Süle, M.; Akbay, E.; Gen, R.; Sezer, K. Retrospective analysis of thyroid incidentalomas detected by [68Ga]Ga-PSMA-11 PET/CT. ENDOCRINE, 2024, 86, 302-309.
10.1007/s12020-024-03847-8

26. Aytan, P.; Gökulu, �.; Durukan, H.; Bozkurt, S.; Taşın, C.; Aslan, E.; Aytan, H. A New Marker for the Diagnosis of Acute Pelvic Inflammatory Disease: Immature Granulocyte. CLINICAL LABORATORY, 2024, 70, 517-524.
10.7754/Clin.Lab.2023.230807

25. Kırmızıer, G.; Altunel kılınç, E.; Yildirim, N. Successful treatment of PASS syndrome with IVIG and anti‐IL‐1 treatment: A case report. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27, -5.
10.1111/1756-185X.15114

24. Balcı fidancı, �.; Yildirim, N.; Derici yıldırım, D.; Eroğlan, �.; Bölgen çimen, �.; Tamer, L.; çimen, M. The role of circulating miRNAs in the diagnosis of osteoporosis miRNAs in osteoporosis. REVISTA DA ASSOCIAÇãO MéDICA BRASILEIRA, 2024, 70, -6.
10.1590/1806-9282.20231724

23. Turgutalp, K. Biopsy-proven BK virus nephropathy in renal transplant recipients: A ­multi-central study from Turkey (BK-TURK STUDY). CLINICAL NEPHROLOGY, 2024, 102, -.
10.5414/CN111300

22. Turgutalp, K. Patients with crush syndrome and kidney disease: lessons learned from the earthquake in Kahramanmaraş, Türkiye. KIDNEY INTERNATIONAL, 2024, 106, -.
10.1016/j.kint.2024.08.008

21. Koç, Z.; özcan, P.; Balcı, Y.; Sayar, H.; Turgutalp, K. Incidental finding of diffuse Tc-99m methylene diphosphonate uptake in lungs in a patient with renal insufficiency and lymphoma. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20, -.
10.4103/jcrt.jcrt_346_22

20. Turgutalp, K. Observational study of immunosuppressive treatment patterns and outcomes in primary membranous nephropathy: a multicenter retrospective analysis. BMC NEPHROLOGY, 2024, 25, -.
10.1186/s12882-024-03784-8

2024
19. Oğuz, �. Analysis of Crush Syndrome Patients With and Without Acute Kidney Injury during the 2023 Kahramanmaraş Earthquake: Experience of a Tertiary Referral Center from Türkiye. TURKISH JOURNAL OF NEPHROLOGY, 2024, 33, -.
10.5152/turkjnephrol.2024.23639

18. öğütmen koç, D.; Bengi, G.; Gül, �.; özlem alahdab, Y.; Altıntaş, E. Turkish Society of Gastroenterology: Pancreas Working Group, Acute Pancreatitis Committee Consensus Report. TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35, -.
10.5152/tjg.2024.24392

2024
17. Turgutalp, K. Epidemiological analysis of the victıms wıth crush syndrome in earthquakes of southeastern Turkey. JOURNAL OF NEPHROLOGY, 2024, 37, -.
10.1007/s40620-024-02051-1

16. Altıntaş, E. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohns disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study. THE LANCET, 2024, 404, -.
10.1016/S0140-6736(24)01762-8

15. Oruç, A.; şumnu, A.; Türkmen, A.; Baştürk, T.; Cebeci, E.; Turgutalp, K.; Seyahi, N.; Tatar, E.; Derici, �. Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group. RENAL FAILURE, 2024, 46, -.
10.1080/0886022X.2024.2341787

14. Oğuz, �. Analysis of patients with crush syndrome with and without intensive care requirement in the 2023 Kahramanmaraşs earthquake: A Single-Center experience from Türkiye. JOURNAL OF CRITICAL CARE, 2024, 81, -.
10.1016/j.jcrc.2024.154707

13. Limon, M.; Tezcan, D. YouTube as a source of information on reactive arthritis: a quality analysis. ZEITSCHRIFTFÜRRHEUMATOLOGIE, 2024, , -.
10.1007/s00393-024-01571-2

2023
12. Limon, M. The assessment of rheumatoid factor levels and hemogram parameters as predictors for rheumatologic disease. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 0, 1-7.

11. Oruçoğlu, N. Comparison of Kinesiophobia in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27, 11508-11516.
10.26355/eurrev_202312_34589

10. Altunel kılınç, E.; Kırmızıer, G.; Oruçoğlu, N.; Arslan, G.; Tombak, A.; Sayar, H. Erdheim-Chester Disease in a Psoriatic Arthritis Patient. ARCIHEVES OF RHEUMATOLOGY, 2023, 39, 136-137.
10.46497/ArchRheumatol.2023.10261

9. Oruçoğlu, N.; Balcı fidancı, �.; Tamer, L. Is the Level of Pentraxin-3 a Valid Biomarker in Axial Spondyloarthritis?. AKTUELLE RHEUMATOLOGIE, 2023, 48, 355-360.
10.1055/a-1990-0705

8. Sezgin, O.; Akpınar, H.; özer, B.; Törüner, M.; Bal, K.; Bor, S. The Abdominal Ultrasonography Results of Cappadocia Cohort Study of Turkey Reveals High Prevalence of Fatty Liver. TURK J GASTROENTEROL, 2023, 34, 652-664.
10.5152/tjg.2023.23067

7. Altıntaş, E. Discharge protocol in acute pancreatitis: an international survey and cohort analysis. SPRINGER SCIENCE AND BUSINESS MEDIA LLC, 2023, 13, -.
10.1038/s41598-023-48480-z

6. Altıntaş, E. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study. ELSEVIER BV, 2023, 165, -.
10.1053/j.gastro.2023.08.038

5. Altıntaş, E. Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study. ELSEVIER BV, 2023, 21, -.
10.1016/j.cgh.2022.12.029

4. şendağ, R.; Bozkurt babuş, S.; Köse, A.; Temel, G.; Turgutalp, K.; Tenekeci, F. Retrospective analysis of patients diagnosed with severe hyponatraemia in the emergency department. SCIENTIFIC SCHOLAR, 2023, 36, -.
10.25259/NMJI_632_20

3. Altıntaş, E. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. MASSACHUSETTS MEDICAL SOCIETY, 2023, 388, -.
10.1056/NEJMoa2207940

2. Erçolak, V. Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey. JAMA NETWORK OPEN, 2023, 6, -.

1. Altıntaş, E. Acute pancreatitis in Turkey: Results of a nationwide multicenter study. ELSEVIER BV, 2023, , -.
10.1016/j.pan.2023.10.005